| Mrs Somary M Vilaysing, MS CCC-SLP | |
|
217 W 17th St, Hays, KS 67601-3301 | |
| (785) 639-0535 | |
| Not Available |
| Full Name | Mrs Somary M Vilaysing |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 217 W 17th St, Hays, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245505296 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3177 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Somary M Vilaysing, MS CCC-SLP 217 W 17th St, Hays, KS 67601-3301 Ph: (785) 639-0535 | Mrs Somary M Vilaysing, MS CCC-SLP 217 W 17th St, Hays, KS 67601-3301 Ph: (785) 639-0535 |
News Archive
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody(TM) platform, today announced the successful second closing of its Series A equity financing round. The Company raised an additional EUR 3.0 million (~USD 4.5 million) from two leading life science investors, Credit Agricole Private Equity and VIB (the prestigious Flemish research institute).
The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity and providing them counseling.
The Alzheimer's Association announced that passage of legislation today by the State Senate to establish a Silver Alert program will help hundreds of thousands in Massachusetts. The legislation, passed unanimously last week in the House, calls for program similar to Amber Alert with distinct differences. Silver Alert will be activated when an adult with Alzheimer's or other type of dementia wanders.
The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that the external data and safety monitoring board (DSMB) has recommended that SNG001, an inhaled formulation of interferon beta, advance to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
› Verified 5 days ago
Mackenzie Schuckman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1107 E 13th St, Hays, KS 67601 Phone: 785-675-0043 Fax: 785-422-7521 | |
Jennifer Sullivan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 94 Lewis Dr, Hays, KS 67601 Phone: 785-625-3257 | |
Marcy Beougher, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Park St, Albertson 103c, Hays, KS 67601 Phone: 785-628-5366 | |
Anne J Bemis, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Park Street, Albertson Hall 103d, Hays, KS 67601 Phone: 785-628-5260 Fax: 785-628-5271 | |
Kreative Speech Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2402 Centennial Blvd, Hays, KS 67601 Phone: 785-639-4603 | |
Mrs. Glenda Susan Bowles, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 94 Lewis Dr, Hays, KS 67601 Phone: 785-625-3257 Fax: 785-625-8557 |